BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon
Launched by BAYER · Sep 19, 2014
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with the diagnosis of relapsing remitting multiple sclerosis or a clinically isolated syndrome.
- • Patients must be on treatment with Betaferon or the decision to treat a patient with Betaferon has been made by the attending physician.
- • Patient and attending physicians must have agreed on the usage of the BETACONNECT auto-injector device.
- • Written informed consent must be obtained.
- Exclusion Criteria:
- • Patients receiving any other disease modifying drug.
- • Contraindications of Betaferon described in the Summary of Product Characteristics.
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Many Locations, , Italy
Many Locations, , Austria
Many Locations, , Spain
Many Locations, , Croatia
Many Locations, , Belgium
Many Locations, , France
Many Locations, , Hungary
Many Locations, , Switzerland
Many Locations, , Bosnia And Herzegovina
Many Locations, , Greece
Many Locations, , Czechia
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials